ストックスクリーナーアプリを入手
173.26
1.34%
2.14
アフターアワーズ：
173.27
0.01
+0.01%
前日終値:
$171.12
開ける：
$170.84
24時間の取引高:
3.21M
Relative Volume:
0.73
時価総額：
$122.62B
収益：
$24.78B
当期純損益:
$3.68B
株価収益率:
33.48
EPS:
5.1743
ネットキャッシュフロー:
$5.29B
1週間 パフォーマンス:
+5.40%
1か月 パフォーマンス:
-10.86%
6か月 パフォーマンス:
-23.73%
1年 パフォーマンス:
-7.17%
1日の値動き範囲:
$167.98
$173.84
1週間の範囲:
$160.93
$173.84
52週間の値動き範囲:
$160.93
$242.80
Danaher Corp Stock (DHR) Company Profile
名前
Danaher Corp
セクター
電話
(202) 828-0850
住所
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, WAT, A
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
173.25 | 121.11B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
449.26 | 167.89B | 45.20B | 6.87B | 6.75B | 18.19 |
IDXX
Idexx Laboratories Inc
|
552.77 | 43.67B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
340.79 | 33.51B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.75 | 32.15B | 7.07B | 1.29B | 993.00M | 4.5355 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-02 | 開始されました | Morgan Stanley | Overweight |
| 2025-10-08 | ダウングレード | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-03-21 | アップグレード | Goldman | Neutral → Buy |
| 2025-03-14 | アップグレード | Stifel | Hold → Buy |
| 2025-02-03 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-13 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-31 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-12-18 | 開始されました | HSBC Securities | Hold |
| 2023-12-13 | 再開されました | Wolfe Research | Peer Perform |
| 2023-12-07 | ダウングレード | Goldman | Buy → Neutral |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-05-01 | 開始されました | SVB Securities | Outperform |
| 2023-04-26 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-10-24 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-08-17 | 再開されました | Bernstein | Outperform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2022-06-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | 開始されました | Bernstein | Outperform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-10 | 繰り返されました | BofA Securities | Buy |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | 繰り返されました | Goldman | Buy |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-04-07 | 再開されました | Robert W. Baird | Outperform |
| 2021-03-03 | 再開されました | Barclays | Overweight |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-25 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 再開されました | Stifel | Hold |
| 2019-10-28 | 繰り返されました | Needham | Buy |
| 2019-10-14 | 再開されました | Credit Suisse | Outperform |
| 2019-07-19 | 繰り返されました | Needham | Buy |
| 2019-06-11 | 開始されました | Piper Jaffray | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-04-17 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2019-02-25 | アップグレード | Janney | Neutral → Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-04-20 | 繰り返されました | Stifel | Buy |
すべてを表示
Danaher Corp (DHR) 最新ニュース
Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence - GlobeNewswire Inc.
Danaher stock (US2358511028): spin-off, diagnostics focus and what the latest numbers reveal - AD HOC NEWS
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead? - The Globe and Mail
Pall to Address a Key Decarbonization Challenge with Additively Manufactured Filtration - PR Newswire
Why The Narrative Around Danaher (DHR) Is Shifting With Bioprocess Recovery And Masimo Deal - Yahoo Finance
Danaher Corp. stock (US2358511028): insider awards highlight leadership confidence after guidance li - AD HOC NEWS
Danaher (NYSE: DHR) director Linda Filler receives stock and option grants - Stock Titan
Danaher (NYSE: DHR) SVP uses 281 shares for tax withholding, retains 8,291 - Stock Titan
[Form 4] DANAHER CORP /DE/ Insider Trading Activity - Stock Titan
Alan G. Spoon (DHR) awarded RSUs and stock options in new Danaher Form 4 - Stock Titan
Danaher (NYSE: DHR) director awarded RSUs and long-dated stock options - Stock Titan
Danaher (NYSE: DHR) director Teri List granted RSUs and stock options as board compensation - Stock Titan
Danaher (NYSE: DHR) awards director Zerhouni RSUs and stock options - Stock Titan
Danaher (NYSE: DHR) director granted RSUs and options in new award - Stock Titan
Danaher (DHR) director Charles Lamanna awarded RSUs and 1,699-share option - Stock Titan
Danaher shares climb as analysts turn more constructive after Q1 guidance lift - Quiver Quantitative
Danaher Corp. stock (US2358511028): restructuring after spin-off, new focus on life sciences - AD HOC NEWS
Northwestern Mutual Wealth Management Co. Acquires 186,584 Shares of Danaher Corporation $DHR - MarketBeat
Danaher stock (US2358511028): Q1 figures, dividend and analyst views in focus - AD HOC NEWS
Danaher stock (US2358511028): earnings momentum and dividend in focus for US investors - AD HOC NEWS
Masimo Corp stock (US5747951003): earnings, Danaher deal and what’s next for the medical-tech spec - AD HOC NEWS
Solid Q1 and Guidance Underlines Why Danaher Corporation (DHR) is one of Steve Cohen’s Large-Cap Stock Picks - Insider Monkey
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus - Yahoo Finance
DoorDash Inc stock (US2358511028): Q1 2026 profit beat keeps growth story in focus - AD HOC NEWS
Danaher Valuation Reset Highlights Recurring Revenues And Lean Operating Framework - Yahoo Finance
Danaher Seen on Path to Growth Reacceleration on Bioprocess Recovery, RBC Says - marketscreener.com
DHR Reinstated by RBC Capital -- Price Target Set at $200 - GuruFocus
Danaher Stock: Analyst Estimates & Ratings - Barchart.com
Contact | Statesman-Examiner - FinancialContent
Danaher stock (US2358511028): spin-offs reshape the medtech group after latest quarterly numbers - AD HOC NEWS
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher (DHR) Receives Outperform Rating from RBC Capital with $200 Price Target - GuruFocus
RBC Capital assumes Danaher stock coverage with outperform rating - Investing.com UK
RBC Capital assumes Danaher stock coverage with outperform rating By Investing.com - Investing.com Nigeria
DoorDash Inc stock (US2358511028): investors weigh latest results and US food delivery outlook - AD HOC NEWS
Jim Cramer Discusses the Performance of Danaher and Its Peers - Insider Monkey
Danaher stock (US2358511028): Shares decline amid four-day losing streak - AD HOC NEWS
The Escalator: Rx&O, Danaher, Ruder Finn and more - Medical Marketing and Media
Transcript : Danaher Corporation Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11 - marketscreener.com
Is Danaher Corporation (DHR) A Good Stock To Buy Now? - Yahoo Finance
Jim Cramer’s Take on 5 Stocks: Home Depot, Procter & Gamble, and Danaher - Insider Monkey
Cepheid Receives CE Marking Under IVDR for Xpert® GI Panel | Newswise - Newswise
10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar
Danaher stock (US2358511028): Shares slide as institutional holdings shift - AD HOC NEWS
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And - Benzinga
Danaher Corporation $DHR Shares Acquired by Swiss Life Asset Management Ltd - MarketBeat
Rainer Blair: Innovative Leader, Danaher Business System Champion, and President and Chief Executive Officer of Danaher Corporation - BBN Times
Danaher Corp. stock underperforms Monday when compared to competitors - MarketWatch
All eyes on Masimo earnings amid pending Danaher takeover - Investing.com
Danaher stock hits 52-week low at $170.19 - Investing.com
Danaher Corp (DHR) 財務データ
収益
当期純利益
現金流量
EPS
0.55%
0.05%
大文字化:
|
ボリューム (24 時間):